Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2007

Mar 1, 2007

30339_dirs_2007-03-01_295fbd57-99af-4379-b968-7e460b423807.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-02-27

Reporting Person: KEATING ROBERT J (Pres. Europe & Asia Pacific, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-02-27 Common stocks A 1 $1.0000 Acquired 27882.7836 Direct
2007-02-27 Common stocks A 3804 $44.9700 Acquired 31686.7836 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-02-27 Stock Option (Right to Buy) $44.9700 A 13169 Acquired 2018-02-27 Common Stock (13169.0000) Direct

Footnotes

F1: Bonus and incentive shares granted on 2/27/07.

F2: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2004 that have vested for performance period III.